Translational Program Grants

INOVATE - Individualised Ovarian Cancer Treatment Through Integration of Genomic Pathology into Multidisciplinary Care

Leader. Professor Anna deFazio

In this program a team of leading scientists and clinicians will develop strategies to treat patients according to ovarian cancer subtype, using new protocols for molecular testing and targeted therapeutic drugs. This will lead to personalised treatment which could improve survival of the 1,300 women in Australia and 200,000 women globally diagnosed with ovarian cancer each year.

Recent Publications

Content pending